Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2026)

Ligand Pharmaceuticals has disclosed Current Taxes across 7 years of filings, most recently posting $1.9 million for Q1 2026.

• Current Taxes for Q1 2026 came in at $1.9 million, up 4.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 4.99% YoY), and the FY2025 annual result was $1.2 million, up 3.34% from the prior year.
• Current Taxes came in at $1.9 million for Q1 2026 at Ligand Pharmaceuticals, up from $1.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $11.4 million in Q2 2023 to a low of $305000.0 in Q2 2025.
• The 5-year median for Current Taxes is $1.8 million (2025), against an average of $3.2 million.
• Peak annual rise in Current Taxes reached 201.08% in 2023, while the deepest fall reached 87.59% in 2023.
• Ligand Pharmaceuticals' Current Taxes stood at $9.7 million in 2022, then slumped by 87.59% to $1.2 million in 2023, then fell by 0.42% to $1.2 million in 2024, then gained by 3.34% to $1.2 million in 2025, then jumped by 52.78% to $1.9 million in 2026.
• The last three Current Taxes figures came in at $1.9 million (Q1 2026), $1.2 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.